AMR SVG Icons location

An Important Message from Ken Keller, President & CEO

The health and safety of American Regent’s employees and customers are our highest priorities.

Read More

Over 50 Years of Specialty Injectables

American Regent develops, manufactures and supplies high-quality sterile injectables for healthcare providers and their patients.

Learn more

Dedicated to Alleviating Drug Shortages

We are committed to collaborating with the FDA to prevent or mitigate drug shortages that impact the health of patients.

Learn more

Check Product Availability

Updated November 25, 2020 08:16 AM

View All

Atropine Sulfate

  • 0.4 mg/mL | 1 mLSingle Dose Vial
  • Shelf Pack — 25

Papaverine HCL

  • 30 mg/mL | 2 mLSingle Dose Vial
  • Shelf Pack — 25

Zinc Sulfate 

  • 5 mg/mL | 5 mLPharmacy Bulk Package Vial
  • Shelf Pack — 25

News Center

American Regent Introduces Estradiol Valerate Injection, USP; AO Rated and Therapeutically Equivalent to Delestrogen®1, 2

Shirley, NY – American Regent announces the introduction and availability of Estradiol Valerate Injection, USP

American Regent, Inc. introduces TralementTM (trace elements injection 4*, USP)

Melville, NY – September 30, 2020: American Regent, Inc. announces the introduction of TralementTM (trace elements injection 4*, USP), the first and only FDA-approved multi-trace element injection.

American Regent Introduces niCARdipine Hydrochloride Injection, USP­; Therapeutically Equivalent to Cardene®

Shirley, NY – May 7, 2020: American Regent announced the introduction of the only FDA approved USP standard Nicardipine Hydrochloride Injection. 

Contact Us

Request a Grant Investigator Initiated Study Request a Certificate of Analysis Expanded Access Policy
Find a Distributor
Please choose your preferred method of contact

By clicking Submit, you confirm that you accept our Privacy Policy and that you agree to your personal contact information being used to contact you and added to our database. If at any time you wish your personal information to be removed from the American Regent database, please submit a message request to corpcommunications@americanregent.com.